SAN DIEGO–(BUSINESS WIRE)–Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today unveiled Enchant v3, the next generation of its multimodal transformer model built to advance end-to-end drug discovery and development. Enchant is the ‘brain’ behind Iambic’s molecular superintelligence platform that, when combined with Iambic’s in-house high-throughput experimental chemistry and biology capabilities, can learn from and predict
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
